Amyloid fibrils are formed by numerous proteins, and the resulting fibrils share a "cross β-sheet" structure. Here we describe how amyloid fibril samples may be prepared for X-ray fiber diffraction and how the patterns may be analysed.
Method Article
Amyloid fibrils are formed by numerous proteins, and the resulting fibrils share a "cross β-sheet" structure. Here we describe how amyloid fibril samples may be prepared for X-ray fiber diffraction and how the patterns may be analysed.
Amyloid fibrils are made up of a misfolded, self-assembled protein organised into a well-defined, repetitive structure. They are well known for their important role in protein misfolding diseases, including Alzheimer's disease and type 2 diabetes, in which the insoluble amyloid fibrils are deposited in the tissues. Furthermore, they have been found to play an important functional role in many organisms, providing strength, scaffolding, and protection. The first structural models of amyloid were informed by X-ray fiber diffraction data collection from bundles of aligned amyloid fibrils. This resulted in early models of the generic cross-β structure which has been superseded by more detailed diffraction analysis from highly oriented and semi-crystalline samples, resulting in details of the organization of peptides into a repetitive architecture. Here, we focused on describing methods of determining the underlying architecture of these fibrils, and we have described the common features of amyloid fibrils from diverse pathogenic, functional, and synthetic sources. We describe the preparation of the samples, data collection, and subsequent data analysis to produce a model structure that can be compared to the experimental data.
Amyloid fibrils were first identified within a group of diseases known as Amyloidoses, in which proteinaceous fibrils accumulate in the extracellular spaces of tissues1. Each disease is characterized by a particular precursor protein which undergoes a conformational change to form highly ordered, stable protein fibrils2,3. The more recent definition of amyloid fibrils now incorporates fibrils that accumulate within the cellular environment. More recently, a number of functional systems have been identified that utilize the amyloid structure to provide stability, adhesion, or even information storage. Despite the wide range of protein structures that can self-assemble to form amyloid fibrils, they all share a cross-β structure4. This cross-β arrangement was first described by Astbury for hen egg white5 and later explained further by Geddes for cross-β silk6. In this protein architecture, the fibrils are made up of β-strands that run perpendicular to the fibril axis, which are then arranged into β-sheets which associate via the side chains to form what was later referred to as steric zippers7. This creates a highly stable organization held together via hydrogen bonds that run parallel to the fiber, alongside hydrophobic, electrostatic, and polar interactions via side chains8.
Early structural studies used X-ray fiber diffraction to interrogate the structure of amyloid fibrils, whereby the fibrils were aligned and oriented to form a bundle of amyloid fibrils which could be placed in the X-ray beam of a diffractometer9,10. A generic structure of amyloid fibrils was generated to fit the diffraction patterns from several amyloid fibrils extracted from human disease tissue or grown in vitro4, and this has provided a basis for further structural descriptions11. In recent years, advances in solid state nuclear magnetic resonance (ssNMR), microcrystal X-ray crystallography, and cryogenic electron microscopy (CryoEM) have provided atomic detail for the cross-β structure11. However, the X-ray fiber diffraction method remains important and useful, and provides information regarding the repetitive organization of the proteins. Furthermore, in some cases, information relating to a longer-range order may be accessible. Fundamentally, X-ray fiber diffraction is often used to confirm the presence of amyloid fibrils formed from different proteins, and the cross-β pattern is one of the principal requirements for a fibrous assembly to be classified as amyloid12.
Here, we describe the methodology used to prepare amyloid fibrils and align them for X-ray fiber diffraction data collection. Furthermore, we provide details of how the diffraction data may be further analyzed to generate a model structure, its predicted diffraction pattern, and compared to diffraction data from ex-vivo-derived fibrils.
Access restricted. Please log in or start a trial to view this content.
1. Preparation of fibrillar samples for X-ray fiber diffraction
2. Data analysis
3. Structural modeling and testing the model using CLEARER
Access restricted. Please log in or start a trial to view this content.
CcbMet example24: Figure 1 shows electron micrographs showing a high density of amyloid fibrils on a grid suitable for preparation of an X-ray fiber sample. Figure 2 describes the different textures that can be generated from fibrous samples fiber bundle (Figure 2A), disk (Figure 2B), mat/film (Figure 2C), and shows t...
Access restricted. Please log in or start a trial to view this content.
X-ray fiber diffraction can be used to evaluate whether a sample is forming an amyloid structure and to gain further insight into the molecular organization of the precursor protein or peptide within the fibers. Here, we have described the methods by which fibrous samples may be prepared for X-ray fiber diffraction, data may be obtained, and then analyzed. Critically, the quality of the data obtained will depend on both the order within the individual fibers. Therefore, initial sample preparation is of major importance, ...
Access restricted. Please log in or start a trial to view this content.
The authors do not have any conflicts of interest to disclose
The authors would like to acknowledge the help of Dr Pawel Sikorski and Professor Edward Atkins with the development of the CLEARER programme and analysis of patterns. The programme was written by Dr O Sumner Makin. This work has been supported by funding from the Alzheimer's Research Trust and the BBSRC.
Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| 0.7 mm diameter X-ray quartzglass capillaries | GLAS, W. Muller, D-13503, Berlin, Germany | Q-07-001-80 | |
| Glass capillaries 1,5 mm borosilicate | Harvard appatus Ltd, (Edenbridge, Kent, UK) | BS4 30-0074 | example, available at other manufacturers |
| Protein crystallography X-ray diffractometer | Various | Various manufacturers |
Access restricted. Please log in or start a trial to view this content.
Request permission to reuse the text or figures of this JoVE article
Request Permission